Provided herein are compounds and methods of preparation of compounds that are capable of functioning as agonists or antagonists of the nicotinic receptor. Also provided are pharmaceutical compositions comprising one or more of these compounds, which may further comprise one or more additional therapeutic agents. Further provided are methods of treatment of various conditions that may be responsive to such activity at the nicotinic receptors, such as nicotine dependence.
Nicotinic Receptor Compounds
Carroll, F., Navarro, H., & Ondachi, P. (2015). IPC No. U.S. Nicotinic Receptor Compounds. (U.S. Patent No. 8981102).